Myriad Genetics (MYGN) Goodwill & Intangibles (2010 - 2026)

Myriad Genetics has disclosed Goodwill & Intangibles across 17 years of filings, most recently posting $192.8 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 64.55% year-over-year to $192.8 million; the TTM figure through Mar 2026 stood at $192.8 million (down 64.55% YoY), while the FY2025 annual figure was $205.0 million, down 62.64% from the prior year.
• Goodwill & Intangibles retreated to $192.8 million in Q1 2026, from $205.0 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for MYGN reached as high as $666.5 million in Q4 2022 and fell as low as $192.8 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $607.3 million (2022), against an average of $521.7 million.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles increased 5.91% — and 2026, when it sank 64.55%.
• A 5-year view of Goodwill & Intangibles shows it stood at $666.5 million in 2022, then declined by 4.44% to $636.9 million in 2023, then decreased by 13.85% to $548.7 million in 2024, then sank by 62.64% to $205.0 million in 2025, then decreased by 5.95% to $192.8 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $192.8 million, $205.0 million, and $214.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.